study-of-the-prognostic-marker-microrna-mir-216a217-in-hepatocellular-carcinoma-patients-and-development-of-an-autologous-vaccine-with-tumor-lysate-pulsed-dendritic-cells-genetically-modified-for-th/#
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.